Steve Hulme - Ingevity Corp Insider
| NGVT Stock | USD 48.52 0.11 0.23% |
Insider
Steve Hulme is Senior Vice President - Performance Chemicals, and President Engineered Polymers of Ingevity Corp since 2022.
| Age | 55 |
| Tenure | 2 years |
| Address | 4920 O'Hear Avenue, North Charleston, SC, United States, 29405 |
| Phone | 843 740 2300 |
| Web | https://www.ingevity.com |
Ingevity Corp Management Efficiency
The company has return on total asset (ROA) of 0.0585 % which means that it generated a profit of $0.0585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2081) %, meaning that it created substantial loss on money invested by shareholders. Ingevity Corp's management efficiency ratios could be used to measure how well Ingevity Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.25 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0). Change To Liabilities is likely to gain to about 51.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 219 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dean Li | Merck Company | 58 | |
| John CPA | MetLife Preferred Stock | 49 | |
| Aliza Scott | FormFactor | N/A | |
| Ramy Tadros | MetLife Preferred Stock | 47 | |
| Stephen Gauster | MetLife Preferred Stock | 53 | |
| Robert Selley | FormFactor | 55 | |
| Stuart Mathews | Gold Fields Ltd | 59 | |
| Styliani Dimaraki | Aegean Airlines SA | N/A | |
| Michael Fleming | Merck Company | 61 | |
| Ioannis Aloukos | Aegean Airlines SA | N/A | |
| Damian Wardle | Cinemark Holdings | N/A | |
| Steven Nott | FormFactor | N/A | |
| Jannie Oosthuizen | Merck Company | 53 | |
| Caren Bedard | Cinemark Holdings | N/A | |
| Jennifer Mauer | Merck Company | N/A | |
| Jarek Kister | FormFactor | N/A | |
| Randolph Clerihue | MetLife Preferred Stock | N/A | |
| Robert Waltermire | Madrigal Pharmaceuticals | 60 | |
| Msc MSc | Gold Fields Ltd | 59 | |
| Michael Kouveliotis | Aegean Airlines SA | N/A | |
| Rosh Bardien | Gold Fields Ltd | 48 | |
Management Performance
| Return On Equity | -1.21 | ||||
| Return On Asset | 0.0585 |
Ingevity Corp Leadership Team
Elected by the shareholders, the Ingevity Corp's board of directors comprises two types of representatives: Ingevity Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingevity. The board's role is to monitor Ingevity Corp's management team and ensure that shareholders' interests are well served. Ingevity Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingevity Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Fitzpatrick, Independent Director | ||
| Stacy Cozad, Executive Vice President General Counsel, Company Secretary | ||
| Stuart Woodcock, Executive Materials | ||
| Daniel Sansone, Independent Director | ||
| John Nypaver, VP Relations | ||
| Christine Stunyo, Senior Officer | ||
| Jean Blackwell, Independent Chairman of the Board | ||
| Ryan Fisher, Vice President, Deputy General Counsel | ||
| Karen Narwold, Independent Director | ||
| Rich White, Senior Vice President - Performance Chemicals, and President Industrial Specialties and Pavement Technologies | ||
| Phillip Platt, Co Officer | ||
| John Fortson, President, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Director | ||
| Mary Hall, Chief Financial Officer, Executive Vice President, Treasurer | ||
| Caroline Monahan, Director Communications | ||
| Frederick Lynch, Lead Independent Director | ||
| Luis FernandezMoreno, Independent Director | ||
| Richard White, Senior Chemicals | ||
| Michael Smith, Executive Vice President and President Performance Chemicals, Strategy and Business Development | ||
| Diane Gulyas, Independent Director | ||
| Daniel Gallagher, VP Relations | ||
| Erik Ripple, VP Officer | ||
| Steven Hulme, Senior Technologies | ||
| S Woodcock, Executive Vice President and President - Performance Materials | ||
| Steve Hulme, Senior Vice President - Performance Chemicals, and President Engineered Polymers |
Ingevity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ingevity Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.21 | ||||
| Return On Asset | 0.0585 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 3.18 B | ||||
| Shares Outstanding | 36.35 M | ||||
| Shares Owned By Insiders | 0.88 % | ||||
| Shares Owned By Institutions | 99.12 % | ||||
| Number Of Shares Shorted | 1.07 M | ||||
| Price To Earning | 16.90 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ingevity Stock Analysis
When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.